Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carisbamate Open-Label Extension in Epilepsy
NCT00210652Phase 2Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Jul 2004
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of carisbamate in focal seizures, generalized tonic-clonic seizure (GTCS), sponsored by SK Life Science, Inc.. Started Jul 2004; status: completed.
02
Drugs
carisbamate
03
Conditions
focal seizuresgeneralized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on NCT00210652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210652.